It's been 6 months and counting with no relief thus far. About Nevro Headquartered in Menlo Park, California , Nevro is a global medical. January 12-15, 2023 | Las Vegas, Nevada. 9% vs 49. S. Nevro is a medical device company and creator of HFX, an innovative, evidence-based treatment for chronic pain of the trunk and/or limbs. • Use only a transmit/receive RF head coil or transmit/receive RF local coil. It runs in accordance with the Declaration of. SENZA II, SENZA OMNIA, OMNIA, SURPASS, SURPASSC, HF10, the HF1- 0 logo, HFX, the HFX logo, HFX iQ, the HFX iQ logo HFX CONNECT, the HFX Connect logo, HFX ACCESS, the HFX Access ,. Important safety, side effects, and risks information. HF10® therapy has demonstrated the ability to reduce or eliminate opioids in ≥65% of patients across six peer-reviewed clinical studies. Thin, flexible wires, called leads, are placed beneath the skin and next to the spine. Nevro says patients will start with a program most likely to provide pain relief, and then adjusts it over time based on patient input and medical data, such as pain scores, activity levels and changes in use of pain medication. All physicians are active users of HF10. It is FDA-approved for driving and is covered by Medicare and most private insurers. 1001 to 5,000. In this study, we retrospectively evaluated the efficacy of HF10 cSCS therapy (NEVRO Corp. Introduction. Biologic complications include infection following SCS implantation, neurologic injury, epidural hematoma, skin erosion, epidural fibrosis, dural puncture, pain, and allergic reaction to the device. 1 beep, confirming the new program setting. Please note that product literature varies by geography. The FDA approved HF10 spinal cord stimulation therapy in 2015, but it was already authorized in Europe in 2010 and Australia in 2011. Page 14 “ HF10 is relief. Kapural, L. NEVRO CORP. 732. Recovery time varies from person to person but typically takes around 6-8 weeks for. • Once desired program is selected, do not press any buttons until the light stops blinking. Component Model Number(s) Nevro IPG(s) NIPG1000, NIPG1500, NIPG2000, NIPG2500 Nevro Percutaneous Leads LEAD10x8-xxB: LEAD1058-50B, LEAD1058-70B, LEAD1058-90BPatients start on the program most likely to provide pain relief, based on the HFX Algorithm™, which was built from more than 20 million datapoints and 80,000 implanted patients;My pain specialist had me try Topiramate, too. Senza, Senza II, HF10, Nevro andmark and logos are registered trademarks owned by Bluetooth SIG, Inc. Patient Manual 11052 Rev A (2015-01-15) [DRAFT] 38 RC2000 Indicator Lights Use the table to help you interpret the lights on the RC2000 Remote Control. All questions or concerns about Nevro Corp. The Senza System has a very similar safety profile to other SCS devices that have been available for many years. , based in Marlborough, Massachusetts; Medtronic, with headquarters in Ireland and the U. Paresthesia-Free with HF10®1,2 With HF10® programs (stimulation at 10,000 Hz),. Additional support resources: Important safety information: the green Program Button until the lights by Program 1 and Program 2 are both OFF. q4cdn. 732. 9415 info@nevro. Learn more about HFX. Patients can also adjust their pain relief programs through an app on their smartphones. 650. Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain. population suffers from chronic low back pain (CLBP) 1 with the accompanying negative effects on mental health, quality of life, and productivity. That program helped immensely and I got off 5. D. The company also provided first quarter and complete full-year 2023 guidance. The HF10 SCS surgical procedures differed from that used for traditional stimulation in three key ways: 1) the two leads were. 906. my Nevro was installed in July, 2017, On the advice from my neurosurgery Doctor, he referred me to a pain specialist an he installed the Nevro H10. The treatment Senza provides (known as HF10 therapy) is a combination of high-frequency (10 kHz) low-amplitude electrical pulses designed to relieve pain and not be felt by the patient, and a. This is why Dr. Safety Information. In addition to Nevro’s proprietary HF10 waveform, Omnia offers the most waveforms on one device and can be programmed to provide waveforms independently or paired with HF10. , April 19, 2021 /PRNewswire/ -- Nevro Corp. is under license. It’s a small device, placed in a same-day, outpatient procedure, that safely works inside your body to significantly reduce your pain and restore your quality of life. How to change group settings 1. Nevro Corp. In summary, the innovative nature of Nevro's Senza SCS system and HF10 therapy is demonstrated on several fronts: • HF10 therapy is the only SCS therapy approved by. Results will be presented at the 2023 North American Neuromodulation Society (NANS) Annual Meeting held from January. Diabetes Care. The generator migrated from its pocket–causing more discomfort. The most common complications of spinal cord stimulation (SCS) therapy are generally related to surgical site infection and hardware malfunction. 650. 19 Apr, 2021, 07:00 ET. This afternoon. Older devices only offered a single type of therapy, but advanced devices. Uniquely offering 2-1200 and 10,000 Hz stimulation, enabling multiple mechanisms of action. (Senza 1000) Remote Control and Charger Quick Start Guide. Less well understood are the adverse neurological effects of this therapy. , a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the settlement of its patent infringement. Program Indicator Battery Level. and international patents. , May 22, 2015 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that provides innovative, evidence-based solutions for the treatment of chronic pain, today announced it has received approval from the U. Tap a group of 5 programs from the 6 groups provided. Germany: +49 157 35996638. REDWOOD CITY, Calif. Senza ® systems offer both direct neural inhibition with 10 kHz Therapy and dorsal column stimulation with lower frequencies. 19,599 likes · 700 talking about this. Mr. To speak with a member of your HFX Care Team please call: US: +1 844-331-1001. The Omnia system is comprised of three. That’s why our physical medicine and rehabilitation expert, Dr. Nevro Hf10 stimulator with paddle. Paresthesia-Free with HF10®1,2 With HF10® programs (stimulation at 10,000 Hz), uniquely offered by Nevro, HFX iQ starts patients on the program most likely to provide pain relief, based on the HFX Algorithm™, which was built from more than 20 million datapoints and 80,000 implanted patients. Choose or Blend Mechanisms of Action. Nevro, and my pain, no help. Approximately 13. We’re here to help you. program used. I get a lot of leg pain from the stimulator but no lumbar pain relief. products should be forwarded to: Nevro Corp. 5. It’s the only spinal cord stimulator to offer both high-frequency and low-frequency programs. As of April 6, 2023, the average one-year price target for Nevro is $45. Expanding Patient Access to Nevro's HF10 Therapy through Broader Imaging Compatibility REDWOOD CITY, California , Nov. FOLLOW THE INSTRUCTIONS FOR USE IF SYMPTOMS PERSIST SEE YOUR DOCTOR/HEALTHCARE. Nevro IPG(s) NIPG1000, NIPG1500, NIPG2000, NIPG2500 Nevro Percutaneous Leads LEAD10x8-xxB: LEAD1058-50B, LEAD1058-70B, LEAD1058-90B Surpass® Surgical Lead LEAD3005-xxB: LEAD3005-50B, LEAD3005-70B, LEAD3005-90B Surpass-C™ Surgical Lead LEAD2005-xxB: LEAD2005-50B, LEAD2005-70B, LEAD2005-90BWhat to expect: spinal cord stimulator implant recovery & restrictions. They are important tools for designing individualized treatment and pain management. S. We have now implanted in excess of 100 HF-SCS devices (Nevro Senza systems; Nevro Corp. That program helped immensely and I got off 5 meds I. HFX includes the widest range of frequencies and waveforms available, uniquely offering you 10 kHz high-frequency and low-frequency programs. Anesthesiology, 123(4) 2 Calculated from patient survey data and functionality measures within the SENZA-RCT. As for programming the Nevro, try starting with program 1, at 3 light bars, do the for 24 hours, record it, and the go to 3 light bars, and record that one, and then 5 bars and record and so on, when you get through all levels and light bars check your notes to see which one helped the most. m. My name is Glen and i have had the Nevro HF10 spinal stimulator implanted since Sept 1, 2021 and the company rep hasn't been able to dial it in on my terrible lower back pain yet. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. What you need to know about nevro hf10 spinal cord stimulationSenza omnia hf10 spine stimulator charger kit nevro chgr2500 charger Www. Product Manuals for Patients. The Chronic Pain Solution The. 3 Million and Plans to Update Guidance When It Reports Second. As with any procedure, your body will need time to rest and heal. Our SCS systems are now approved to deliver 2. Recent Business Highlights and. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it has received approval from the U. Programs 8 Programs 1 Programs 1 Programs Preferred Waveform Regiona 1 Relief Regiona 1 Relief Bilateral leg Back Overall Pain Relief 85% 88% 76% 1 Programs 1 Programs 1 Programs Patient Quote: Slept all night! Functional Improvement: Walked a mile! Sleep Improvement: Doing great!Nevro Corp. Nevro Corp. Headquartered in Redwood City, California, Nevro is a global medical device company focused on delivering comprehensive, life-changing solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. Posted by elsa @elsa, Jul 26, 2020. To change the program, press the Program Selection Button . The Senza ® System, Senza II™ System, and the Senza ® Omnia™ System are the only SCS systems that deliver Nevro's proprietary HF10 ® therapy. , April 24, 2023 /PRNewswire/ -- Nevro Corp. mark and logos are registered trademarks owned by Bluetooth SIG, Inc. 888. The safety of HFX has been thoroughly studied and proven. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it has received approval from the U. Nevro Corp. . 251. All questions or concerns about Nevro Corp. • Once desired program is selected, do not press any buttons until the light stops blinking. , Nevro. NEVRO CORP. Posted by mamabear62 @mamabear62, Jun 23, 2020. Nevro Device Crosswalk by Product Code The following Nevro products have Level II HCPCS codes that can be billed on the UB-04 claim form. • Once desired program is selected, do not press any buttons until the light stops blinking. NEVRO’S SENZA SYSTEM, DELIVERING HF10™ THERAPY. 7 Medicare accepts this code, along with all other applicable C-codes, on. HF10 is delivered by the Senza Spinal Cord Stimulation system. Nevro Corp. Find a Physician - HF10. ET to Discuss the FDA Approval and Operating Results for the First Quarter 2015 Nevro Corp. The. Thornal succeeds D. I didn't have this pain prior to surgery. For uninsured patients, typical out-of-pocket costs for spinal cord stimulation are $15,000 - $50,000 or more. Traction of HF10: after the trial was completed in 2015 and approved, Nevro’s product grew pretty rapidly to over $300M in sales. S. HF10 has demonstrated significant relief for both back and leg pain. (NYSE: NVRO ), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of. My name is Glen and i have had the Nevro HF10 spinal stimulator implanted since Sept 1, 2021 and the company rep hasn't been able to dial it in on my terrible lower back pain yet. Easily pair the widest array of waveform types, including paresthesia-based. Nevro HF10™ Therapy: A Combination of Four Key. But to me, it seems you may need, if you haven't had it already, is to have it adjusted and programmed again. Comparison of Spinal Cord Stimulators from Boston Sci. • Once desired program is. The good thing is that you can do a trial first and the procedure is reversable if there are problems. HFX has a similar safety profile, including side effects and risks, to other. , Nevro. Biomedicines, 10, 2630. On day six, they took an X-ray and saw that the leads had moved a lot. If you need support, please call: +1-844-331-1001. , et al. Siller replaces Niamh. SENZA II, SENZA OMNIA, OMNIA, SURPASS, SURPASS-C, HF10, the HF10 logo, HFX, the HFX logo, HFX iQ, the HFX iQ logo, HFX CONNECT, the HFX Connect logo, HFX ACCESS, the HFX Access. Nevro Hf10 stimulator with paddle. Nevro reviewFda approves spinal cord stimulation system with superiority labeling Hf10 manualslib nevroNevro corp receives ce mark for senza omnia scs. [9] The most significant biologic complication results from implanting the SCS device. Midwest Interventional Spine Specialists (M. Various stimulation programs were provided to target the dorsal columns of C 2-C 5 (frequency: 10 kHz, pulseNevro Corp. In addition to Nevro's proprietary HF10 waveform, Omnia offers the most waveforms on one device and can be programmed to provide waveforms independently or paired with HF10. • Figure 1 shows that the top of the Implant (in yellow box) is at the center of the Charging. Only a physician can recommend a specific. SCS has four programmable parameters: contact (electrode) selection, amplitude, pulse width, and frequency. 1 beep, confirming the new program setting. Nevro Corp. S. Wisconsin. 650. The FDA approval for HF10 therapy came with a label of superiority over traditional SCS therapy, indicating that HF10 therapy was found to be statistically superior to traditional Nevro's battery is designed to last 10+ years at all common programming settings. However, in three patients the trial has. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that Nevro's HFX 10 kHz Therapy is the only form of spinal cord stimulation (SCS) therapy to be referenced by the American Association of Clinical Endocrinology. S. It is implanted under the skin and has an inbuilt battery. Consultation and sales of outsourced surgical equipment to operating rooms and physician's clinics. $100M to $500M (USD) Headquarters. Keith Grossman, who is retiring as Chief Executive Officer and President, also effective April 24, 2023. Was on opiates for 8 years until I attended & graduated from Mayo's 3-week Pain Rehab Program in 2018. Nevro’s Senza spinal cord stimulation (SCS) system, delivering HF10. Expanding Patient and Surgeon Access to Nevro's HF10™ Therapy, Labeled Superior to Traditional SCS Therapy for Chronic Back and Leg Pain Nevro Corp. Nevro Corp. In May 2015, Nevro’s Senza® SCS system, which is the only SCS system that delivers HF10 therapy, was approved by the FDA. 1 Kapural L. I have had 8 back surgeries over the last 3 1/2 years, the last ones January 2018 which L1-L5 was fused. Manuals are subject to change; the most current version is available on this page. They have tried multiple programs on me to no. Access to the clinical evidence portfolio supporting our therapy. A spinal cord stimulator is an implanted device that is controlled outside the body by the patient. Description of the technology. Nevro hereby declares that the Senza® system is in compliance with the essential requirements and other relevant provisions of the R&TTE Directive (1999/5/EC). The safety of HFX has been thoroughly studied and proven. Learn about how a spinal cord stimulator can help you get rid of your chronic pain. Ability to provide or blend 2 distinct mechanisms of action. For more than a decade, HF10 has offered a next. is under license. Please note that product literature varies by geography. MRI Guidance. Food and Drug Administration (FDA) for the Senza ® Omnia ™ Spinal Cord Stimulation (SCS) System. I definitely had improvement in my butt and legs but not as sure on my back. Nevro Corp. MENLO PARK, Calif. The potential uses for spinal cord stimulation include heart-related chest pain, nerve pain, and spine or back pain. Other subjects expressing preference for the 100%DC program had their 14%PD program converted to a 50%PD program (20 seconds ON and 20 seconds OFF). 2 attorney answers. ¹ HFX. HFX is a comprehensive solution that includes a Senza spinal cord stimulation system. The Senza spinal cord stimulation (SCS) system (Nevro) is a neuromodulation device that delivers electrical impulses to the spinal cord. Knowing these fundamentals will aid in providing superior pain relief to patients. Nevro HFX Chronic Pain Relief. Follow. 39. Senza, Senza II, Senza Omnia, HF10, Nevro and the Nevro. Food and Drug Administration (FDA) for the Senza HFX iQ spinal cord stimulation (SCS) system. This is the full video interview with one of our patients who had life-changing success with the Nevro HF10 Spinal Cord Stimulator. A spinal cord stimulator system is made of four parts: Impulse Generator (IPG): this is a computer that is roughly the size of a matchbox that controls the impulses delivered to the spinal cord. We have 2 Nevro HF10 manuals available for free PDF download: Booklet, Accessory Manuals. The Omnia system is the first and only. 1800 Bridge Parkway Redwood City, CA 94065. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced its fourth quarter and full-year 2022 financial results. 650. These mechanisms can be used simultaneously or independently to help manage. Food and Drug Administration in 1984. HF10 is an FDA-approved device that uses spinal cord stimulation to help reduce chronic back and leg pain. Excellent Safety and Efficacy Profile. Food and Drug Administration (FDA) for the Senza HFX iQ spinal cord stimulation (SCS) system. This is different compared to older stimulators that work by creating tingling in a patient’s pain area to. back pain, and leg pa in. Patients start with the stimulation program most likely to provide pain relief based on our. HFX has a similar safety profile, including side effects and risks, to other. Use only product literature from the region where the patient procedure was performed. A couple of thoughts based on my experience and research. The Nevro device delivers electrical energy to areas around the spine and provides. 3. Ability to provide or blend 2 distinct mechanisms of action. I'm tagging a few members like @sbrown293 @martyk @marieh @pusher @scruffy1 @dogsma @chefmike2010 @lifetimepain @jimhd who have experience with spine stimulators, some of whom had the Nevro HF10. products, including any serious incident that has occurred in relation. It is a safe and effective treatment option that has received superior outcomes and. Nevro's innovations in SCS, including the Senza® and Senza II™ systems and HF10™ therapy, are covered by more than 140 issued U. We evaluated safety in a global SCS registry for. About Nevro“I will be forever grateful for the miracle of pain relief with HF10. ET to Discuss the FDA Approval and Operating Results for the First Quarter 2015 Nevro Corp. By delivering electrical pulses directly to the spinal cord, this therapy blocks pain signals from reaching the brain. It's been 6 months and counting with no relief thus far. SENZA II, HF10, the HF10 logo, 10 kHz Therapy, HFX, the HFX logo, HFX iQ, the HFX iQ. This past February I had enough and opted for multi level fusion L1-Si. 76% of people with back pain and 73% of people with leg pain experienced at least 50% pain relief with HFX. From January 2016 to August 2018, seventy-three patients were enrolled with a trial to assess the response to the HS10 previous to undergo a permanent implant (Fig. m. Mr Gliner has a patent for HF10 therapy and related issued to Nevro Corp. S. Nevro Corp. Opioid-based painkillers are often necessary for chronic pain. 2 CLBP is a major cause of disability and cost to our healthcare system, 1 accounting for 3. , Feb. I have not done the trial yet, but that's the first step. Results will be presented at the 2023 North American. After 12 months of treatment with 10-kHz SCS. Senza, Senza II, Senza Omnia, HF10, Nevro and the. In contrast to other currently available systems that use frequencies in the. Expanding Patient Access to Nevro's HF10® Therapy Through Broader Imaging Compatibility Nevro Corp. S. Remote Control and Charger Quick Start Guide. The company, headquartered in. It’s a minimally invasive method that does not necessitate the use of medicines or significant surgery. Senza ® systems offer both direct neural inhibition with 10 kHz Therapy and dorsal column stimulation with lower frequencies. com MDSS GMBH Schiffgraben 41 D-30175 Hannover, Germany Australian Sponsor Emergo Asia Pacific Pty LtdNevro's SENZA-PDN study, the largest randomized clinical trial (RCT) of spinal cord stimulation treatment conducted thus far, compares HF10 therapy plus Conventional Medical Management (CMM) to. Nevro Corp. All questions or concerns about Nevro Corp. This approval is specific to Nevro's unique 10 kHz stimulation, and Nevro now has the only spinal cord stimulation system approved by the FDA with a specific indication to treat PDN. Novel 10-kHz High-frequency Therapy (HF10. These mechanisms can be used simultaneously or independently to help manage. Changing Stimulation Level. SENZA, SENZA II, HF10, the HF10 logo, 10 kHz Therapy, HFX, the HFX logo, HFX iQ, the HFX iQ logo, HFX ACCESS, the HFX Access logo, HFX COACH, the HFX Coach logo, RELIEF MULTIPLIED,. Any certified/specialized medical centres for the devise in EU area can assist with nevro hf10 SCS. 251. , Nevro. Sanitation Program Manager Dayton, OH. Posted on May 24, 2018 ; Infections are known risks of these procedures. and any use of such marks by Nevro Corp. Nevro is a medical device company headquartered in Redwood City, California. Paired waveforms offer the benefit of both functions simultaneously. Comparison of Spinal Cord Stimulators from Boston Sci. 76% of people with back pain and 73% of people with leg pain experienced at least 50% pain relief with HFX. Each parameter needs to be accounted for when assessing which program works for which patient. 9600 Book Online Menu. MyChart. Full Body MRI7 All Nevro systems are conditionally approved for full body MRI scans. REDWOOD CITY, Calif. This innovative therapy relies on advanced spinal cord stimulation (SCS) science. It is the most effective SCS solution, with the highest demonstrated success rate for chronic leg and back pain. 1800 Bridge Parkway Redwood City, CA 94065 USA 1. Mainly burning in. I experienced pain level 10 until i became settled on my back. S. The ability to pair frequencies allows Omnia to pair HF10 – the most studied SCS therapy with over 55,000 patients treated across the world – with other. HFX iQ is a smart pain management system that uses the largest clinical SCS dataset to recommend the starting program most likely to provide pain relief 1 and adjusts therapy based on each patient's responses to. S. I have complete confidence in this unit because the temporary one that they inserted worked unbelievably well. The study found HFX provided significantly better and longer-lasting pain relief from back and leg pain than other spinal cord stimulators 4-5. From what I have read, the Nevro HF10 has been very successful at helping people with back pain. S. 1 Kapural L. 5’ x 15. 2016, CMS created a new device category (C1822) for HF10 therapy based on the clinical evidence that fulfills the substantial clinical improvement criteria. That’s because HFX is the most advanced spinal cord stimulator available. my lower legs. • Once desired program is selected, do not press any buttons until the light stops blinking. Has anyone tried a device called HF10 ? It’s a device which stimulates your spinal cord to help relieve back and leg pain. Dr Mekhail. It’s a small device, placed in a same-day, outpatient procedure, that safely works inside your body to significantly reduce your pain and restore your quality of life. S. products, including any serious incident that has occurred in relation to the device, should be forwarded to:. You will first go through a trial phase where you and your doctor evaluate the therapy to see if its right for you. Results: Twenty-three of 24 subjects (95. The recharge process typically includes: Taking the fully-charged charger (from a base station) and placing it over the skin where the implanted SCS device is located. “I am so eager to get up & get my day going now,” said Krista, who found relief with HF10 in January 2020 after suffering from chronic debilitating pain since…HF10 Therapy Labeled as Superior to Traditional SCS Therapy for Chronic Back and Leg Pain Conference Call on Monday, May 11 at 8:30 a. Switzerland: +41 26 539 1028. So far we have gone through 4 programs and I have had no response. I had the Nevro HF10 trial for 11 days it wasn't until the 7th day that I achieved over 75% pain reduction on pain that had never ceased in intensity for 10 years. About Nevro. I am scheduled to have the Nevro Hf10 spinal stimulator put in at the end of August. Make sure the light above your program number is brightly illuminated. If you need more information about compatibility with MRI scans, please refer to the Patient Manual, and consult with your doctor, or contact Nevro’s Technical Services department at [email protected] or +1-888-895-8105. Company Announces Preliminary, Unaudited. Was on opiates for 8 years until I attended & graduated from Mayo's 3-week Pain Rehab Program in 2018. The four biggest makers of spinal-cord stimulators are Boston Scientific Corp. Had the device removed–leads were out of place and broken out of their silicone sheaths. REDWOOD CITY, Calif. HFX iQ starts patients on the program most likely to provide pain relief, based on the HFX Algorithm™, which was built from more than 20 million datapoints and 80,000 implanted patients. 251. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it has now initiated the U. All questions or concerns about Nevro Corp. (NYSE: NVRO), a medical device company that is providing innovative evidence-based solutions for the. Nevro HFX is a small, FDA-approved device that treats chronic pain at the source. It is a non-addictive, minimally-invasive and reversible option that provides patients with long-term chronic pain relief. SECTION III – ADMINISTRATION AND MANAGEMENT OF NEVRO’S CONFLICT MINERALS PROGRAM Roles and Responsibilities Executive Sponsor: The Executive Sponsor of Nevro’s. The Senza System is used as an aid in the management of chronic intractable pain of the trunk and/or limbs. But, this risk can be lowered by. ; Nevro, in Redwood City. 9415 info@nevro. Yes, that's a drug for epilepsy but it also is supposed to block nerve pain. HFX has a similar safety profile, including side effects and risks, to other. Why HFX TM. Compared to traditional spinal cord stimulation, where only 49% of people with back and leg. And the good news is since spinal cord stimulation is a well-established therapy it’s covered by most major insurance plans. This is a high frequency device so I don’t have any of the tingling feeling that are typical of the low frequency units.